1. Medtech Insight
  2. >>Policy & Regulation

Biden Administration Upholds ITC Ruling That Could Result In Apple Watch Ban

 
• By Brian Bossetta

President Joe Biden has upheld a December ruling from the International Trade Commission that tech giant Apple infringed on wearable digital health technology from Silicon Valley-based AliveCor. The ruling could mean a ban of some Apple Watches in the US.

Cracow, Poland - 15 May 2019: Man using Apple Wach Series 4 in silver color to do an ECG or EKG test (Electrocardiography) - Image
• Source: Shutterstock

The Biden Administration has decided not to overturn a ruling by the International Trade Commission (ITC) that could ban some Apple Watch sales in the US, depending upon the outcome of a lawsuit alleging patent infringement.

In December, the ITC ruled in favor of AliveCor, Inc., a medical device company in Mountain View, CA, which claimed Apple infringed upon its patented electrocardiogram technology

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Regulation

More from Policy & Regulation

What’s A Diagnostic? WHO Wants To Know

 
• By Elizabeth Orr

The World Health Organization is seeking input from stakeholders to create an official definition of the term ‘diagnostics.’ This initiative follows a 2023 resolution aimed at enhancing global diagnostics capacity; the definition, it is hoped, will help drive the creation of effective health policies. Comments will be accepted until 23 May.

‘Help Us Deregulate’: RFK Announces RFI For Trimming Government Health Agencies

 
• By Brian Bossetta

HHS Secretary Robert F. Kennedy, Jr. is asking the public to help cut waste across the government’s health agencies. Kennedy announced a 60-day comment period allowing the public to take part in a broader federal initiative to reduce regulations and increase transparency.

MedTech Europe’s Bisazza Urges Action As US Tariffs Jeopardize Critical Global Supply Chains

 
• By Amanda Maxwell

The intricate assembly of medical devices, often involving over 1,000 globally sourced components, faces severe disruption due to new US tariffs. These barriers could halt production and devastate small and medium-sized enterprises (SMEs), MedTech Europe’s CEO, Oliver Bisazza, warns in an interview with Medtech Insight.